Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
77 /100
COMPONENT-LIMITED
Score updated Aug 28, 2026

CMND — Clearmind Medicine Inc. Dilution Risk Tracker

Track CMND dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track CMND — Get alerts when the score changes →

As of August 28, 2026, Clearmind Medicine Inc. (CMND) has a DilutionWatch DilutionScore of 77/100, rated CRITICAL dilution risk. This is a component-limited score because one or more material inputs are unavailable or not applicable. Clearmind Medicine Inc. has a market capitalization of $3.65M, 158.1K shares outstanding, 3 institutional holders tracked. Stored dilution-related fields include shelf registration capacity of $10.00M.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
100
💰 Cash Runway
40
📊Float Risk
⚠️ Warrant Exposure
40
🔄 Convertible Debt
85

Dilution Forecast

⛈️
Warning
High probability of dilution event
model est. 39%
🔁 Convertible Conversion model 60%
• Major convertible overhang: 2182% potential dilution
• Convertible risk score very high (85/100)
💰 Capital Raise model 20%
• Active shelf registration ($10M, 274% of market cap)
📉 Score Deterioration model 15%
• Score already CRITICAL (77/100) — events likely imminent
🔔 Track CMND — Get forecast alerts →

Market Data

Market Cap$3.65M
Shares Outstanding158.1K
FloatN/A
Cash$10.35M
Debt$8.0K
Short InterestN/A

Institutional Holdings

3 institutional holders · 6.7K shares
#1 AdvisorShares Investments, LLC 6.6K shares
#2 Royal Bank of Canada 14 shares
#3 JPMORGAN CHASE & CO 5 shares

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest47.9K
Days to Cover1.0
% of FloatN/A
FINRA data as of Jul 31, 2026

Recent SEC Activity

EFFECT EFFECT 2026-06-18
4 INSIDER TRANSACTION 2026-06-18
4 INSIDER TRANSACTION 2026-06-17
4 INSIDER TRANSACTION 2026-06-16
6-K 8K EVENT 2026-06-12
Full SEC filing analysis available with free account

Recent News

Factual CMND Dilution Snapshot

Clearmind Medicine Inc. (CMND) has a DilutionScore of 77/100, rated Critical dilution risk. Score date: August 28, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

Track CMND Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking CMND — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

Related Stocks — CRITICAL Risk

Other CRITICAL dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 8,024+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations

Score Coverage Note

More Research for CMND
CMND FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.